Related Experiment Video

Updated: Jul 13, 2025

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K

Correction: Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective

René Bruno, Mathilde Marchand, Kenta Yoshida

    Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
    |October 13, 2023
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
    13:34

    A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

    Published on: April 6, 2016

    10.2K
    Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
    08:17

    Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

    Published on: June 7, 2015

    15.8K

    Related Experiment Videos

    Last Updated: Jul 13, 2025

    Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
    09:44

    Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

    Published on: January 29, 2019

    10.1K
    A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
    13:34

    A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

    Published on: April 6, 2016

    10.2K
    Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
    08:17

    Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

    Published on: June 7, 2015

    15.8K

    Related Concept Videos

    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    359
    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
    359

    Articles linked to this work by shared authors, journal, and citation graph.

    Prognostic Value of Frailty and Other Risk Factors in Patients Undergoing Lower Limb Revascularisation or Primary Major Lower Limb Amputation.

    Cureus·2026

    Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology.

    CPT: pharmacometrics & systems pharmacology·2026

    A transcriptional biosensor reveals mechanisms of α-ketoglutarate signaling to chromatin.

    Science (New York, N.Y.)·2026

    Patient Perspectives on Palliative Care in Pulmonary Arterial Hypertension in the United States.

    Pulmonary circulation·2026

    Payload-Based Clinical Pharmacology Review of Approved Antibody-Drug Conjugates: Commonalities and Considerations for Streamlined Development.

    Clinical pharmacology and therapeutics·2026

    Assessing contribution of effect in oncology combination therapies: lessons learned to inform and optimize future registrational trial designs.

    The oncologist·2026

    A Phase II Trial of Pembrolizumab plus Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Biliary Cancer.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    BRIGHTLINE-1: When a Negative Trial Reveals Two Active Therapies.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    EZH2 Inhibition and Myeloid Risk: A Feature of On-Target Biology.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    The pan-tumor landscape, allelic status, and genomic complexity of SMARCA4 alterations.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Clinical, genomic, and spatial transcriptomic features of pancreatic adenosquamous carcinoma support subtype-specific therapeutic strategies.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Phase II trial of First-Line Axitinib Plus Nivolumab in Patients with Advanced Mucosal Melanoma.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us